Gapping up
In reaction to strong earnings/guidance: ZLTQ +28.6%, EXPE +17.5%, ALU +15.2% (also Alcatel-Lucent and NantWorks announce definitive agreement by which NantWorks will acquire ALU's Digital Multimedia Solutions product business unit; financial terms not disclosed), SPRT +11.3%, FLDM +10.5%, PFPT +10.1%, (light volume), CRR +8.3%, (light volume), ANIK +7.2%, QUIK +6.9%, (light volume), SSNI +6.5%, ITMN +5.6%, (light volume), UNTD +5.3%, SWKS +5.1%, WMB +4.9%, TRN +4.7%, ANR +3.9%, (light volume), ATML +3.6%, THOR +3.2%, (Thoratec upgraded to Buy from Hold at Canaccord), AFFX +3%, (light volume), OI +3%, (light volume), BT +2.9%, (light volume), CTRX +2.6%, (light volume), FB +2.6%, MCHP +2.6%, EL +2.6%, (ticking higher), CAVM +2.5%, HBI +2.4%, CAH +2.4%, (light volume), PRGO +1.9%, FLT +1.7%, MA +1.6%, IPI +1.4%, (light volume), POWI +1.1%, ARRS +1%, PRAA +0.9%, (light volume), MTGE +0.4%, (light volume),.
Select online travel names showing strength following EXPE results: OWW +4.6%, TRIP +1.6%, PCLN +1.2%, CTRP +1.1%.
Other news: OPTT +28.3% (awarded $2.6 mln contract by Mitsui Engineering & Shipbuilding for development and supply of Japan Utility PowerBuoy system), XOMA +14.4% ( Results From Two Phase 2 Studies in XOMA's Gevokizumab Proof-of-Concept Program Are Very Encouraging and Compelling), NQ +11.5% (looking around for anything new), PRAN +10.2% (continued strength), CETV +9.2% (modestly rebounding), VVUS +3.7% (Newly Published Study Finds Qsymia Achieves Greater Weight Loss at Lower Doses Than Either of Its Components as Monotherapy), CRTO +2.9% (recent IPO), JNY +2.6% (following late spike after NYPost James Covert reported 'NY POST EXCLUSIVE on auction process of Jones Group coming shortly'), FF +2.5% (FF to replace AOS in the S&P SmallCap 600), GLW +1.2% (announces $1 bln accelerated share repurchase ), DB +1.1% (still checking), AOS +0.8% (AOS to replace SKS in the S&P MidCap 400), TEVA +0.8% ( FDA clears commencement of Phase 3 chronic heart failure trial ), YELP +0.7% (prices 3.75 mln share follow-on offering at $67.00 per share ), BP +0.7% (RDS.A and TOT reported), ELN +0.7% (PRGO reported), BUD +0.2% (positive mention on MadMoney).
Analyst comments: HTS +0.8% (upgraded to Buy from Neutral at Compass ), HES +0.6% (upgraded to Outperform from Neutral at Credit Suisse)